FREE ELECTRONIC LIBRARY - Dissertations, online materials

Pages:     | 1 || 3 | 4 |

«ABCD GUIDELINES ON: 2. FELINE HERPESVIRUS-1 2.1 Biology of the virus 2.1.1 Virus properties 2.1.2 Epidemiology 2.2 Pathogenesis 2.3 Immunity 2.3.1 ...»

-- [ Page 2 ] --

Because the very low amounts of viral nucleic acids detectable by PCR may not be associated with disease, PCR positive results should be interpreted with caution. The sensitivity of PCR depends on the test (Maggs and Clarke, 2005) and it is advisable to use a system that includes a control that detects feline DNA to give an indication of how much material was on the swab, and to check for substances that might inhibit PCR. Due to its high sensitivity, PCR may also detect viral DNA in scrapings of the cornea and/or tonsils suggesting nonproductive infection (Maggs et al., 1999b; Reubel et al., 1993; Stiles et al., 1997a).

Consequently its predictive value for clinical infection may be poor, depending on the test sensitivity, the samples analysed (corneal scrapings and biopsies more frequently yield positive results than conjunctival ones) and the population tested (e.g. shelter cats are more likely to test positive than owned pet cats).

Additionally, many if not all PCR tests are able to detect FHV-1 DNA in modified-live vaccines (Maggs and Clarke, 2005) and it is not presently known if vaccinal strains may be detected in recently vaccinated animals and if so, for how long after vaccination.

A positive PCR result may represent low level shedding or viral latency and does not mean that the virus is responsible for clinical signs, although it indicates the possibility of recurring signs in the future. However, when quantitative real-time PCR is used (Vögtlin et al., 2002), the viral load present in the material tested may provide additional information on the etiological importance of the agent. When high loads are present in the nasal secretion or tears, this suggests active replication and therefore involvement of the virus in the clinical signs. If low copy numbers are detected in corneal scrapings, this would indicate a latent infection.

Molecular diagnosis may be more convenient for clinicians, because the use of fluorescein does not interfere with specificity of the test and samples can be mailed over several days at ambient temperature (Maggs 2005). It also allows the simultaneous detection in the same samples of other feline pathogens frequently implicated in respiratory and ocular diseases, especially Chlamydophila felis and, less reliably, feline calicivirus (Helps et al., 2003;

Marsilio et al., 2004). Virus isolation If PCR is not available, virus isolation (VI) is an alternative method of diagnosing FHV-1 infection. Virus isolation is less sensitive than PCR but does indicate that replicationcompetent virus, not just DNA is present. VI also allows the simultaneous detection of feline calicivirus.

In cats undergoing primary FHV-1 infection, the virus can be easily detected by isolation from conjunctival, nasal or pharyngeal swabs or scrapings, or from post-mortem lung samples But during chronic infections when the aetiological origin of disease has to be confirmed, VI may be more difficult.

Asymptomatic carriers may also be detected by VI and both positive and negative predictive values of VI appear to be low in some studies (Gaskell and Povey, 1977; Maggs et al., 1999b). Samples must be collected before application of fluorescein or Rose Bengal stain ABCD guidelines on Feline Herpes Virus-1 7/17 which can inhibit viral replication in cell culture (Brooks et al., 1994; Storey et al., 2002) and clinical specimens should be sent quickly to the laboratory and is ideally refrigerated during shipping. For logistic reasons and despite its good sensitivity in acute disease, VI is not routinely used for FHV-1 infection diagnosis. Immunofluorescent assay (IFA) FHV-1-specific proteins can be detected by immunofluorescent assay (IFA) on conjunctival or corneal smears or biopsy. As for VI, fluorescein instillation should be avoided before sampling. For IFA, this may give false positive results and interfere with the interpretation of the test. IFA has been reported to be less sensitive than VI or PCR, especially in chronic infections (Nasisse et al., 1993; Burgesser et al., 1999). Although no correlation between VI and IFA testing has been observed, combination of VI and IFA may predict the presence of virus better than either test alone (Nasisse et al., 1993; Maggs et al., 1999b). Because of lack of sensitivity and the interference with fluorescein, often used in ophthalmology practice, IFA is not the most suitable diagnostic test in chronic ocular diseases (Nasisse et al., 1993).

2.5.2 Detection of infection by serology FHV antibodies can be detected by serum neutralization or ELISA in serum, aqueous humour and cerebrospinal fluid (Dawson et al., 1998; Maggs et al., 1999b). The seroprevalence is very high in cats due to natural infection and vaccination. Consequently, the presence of specific antibodies does not correlate with disease and active infection (Maggs et al., 1999b).

Moreover, antibody detection does not allow differentiation between infected and vaccinated animals, neutralizing antibodies are undetectable until 20 to 30 days after a primary infection and antibody titres may be low in animals with either acute or chronic disease. Consequently serology has a very limited value in the diagnosis of feline herpesvirus infection (Nasisse and Weigler, 1997; Maggs et al., 1999b; Maggs, 2005).

2.6 Feline herpesvirus disease management

2.6.1 Supportive Treatment The restoration of fluids, electrolytes and the acid-base balance (e.g. replacement of losses of potassium and bicarbonate due to salivation and reduced food intake), preferably by intravenous administration, is required in cats with severe clinical signs. Food intake is extremely important. Many cats with FHV infection do not eat because of their loss of smell due to nasal congestion or because of ulcers in the oral cavity. Food may be blended to cause less pain when eating, should be highly palatable, and may be warmed up to increase the smell. Appetite stimulants (e.g. cyproheptadine) may be used. If the cat is not eating for more than three days, placement of a nasal or an oesophageal feeding tube is indicated.

Antibiotics should be given to treat all acute cases of feline upper respiratory tract disease to prevent secondary bacterial infections. Broad-spectrum antibiotics with good penetration in the respiratory tract should be given.

Cats severely affected by FHV-1 need intensive nursing care and appropriate supportive therapy is very important. If there is nasal discharge, this should be cleaned away several times a day with physiologic saline solution, and be treated afterwards with local ointment.

Drugs with mucolytic effects (e.g. bromhexine) may be helpful. Eye drops or ointment can be

–  –  –

n.d. = not determined; eod = every other day; sid = once daily; bid = twice daily; tid = three times daily.

It should be noted that the above drugs may not be readily available or licensed for cats.

Other drugs have been proposed for the treatment of FHV-1 ocular infections, including bromovinyldeoyuridine, cidofovir, HPMA, pencyclovir, ribavirin, valacyclovir, vidarabine, foscarnet and lactoferrin. However, the efficacy of these drugs is not supported by appropriate data.

2.7 General recommendations on vaccine type and vaccination protocol

FHV-1 infection is common and may induce severe disease. ABCD therefore recommends that all cats should be vaccinated against FHV-1. FHV-1-vaccines provide protection by inducing both humoral immunity, associated with a serological response, and cellular immunity. Vaccination provides good protection against clinical disease, but in common with many localised respiratory tract infections, it does not provide 100% protection (approx.

90+% reduction in clinical scores has been achieved following experimental challenge soon after vaccination)(Gaskell et al., 2007). Less effective protection can be expected in some vaccinated individuals in particular circumstances following exposure to virus, e.g. extreme challenge, immunosuppression. There is no evidence that any variation in isolates of FHV-1 creates problems in protection provided by vaccination.

Vaccination protects from the development of clinical signs, but not necessarily from infection. However, there is some evidence that it can reduce subsequent excretion of virus.

(Gaskell et al., 2007).

Currently, FHV-1 vaccines are usually combined with FCV, either in divalent vaccines (only in some countries) or, more commonly with other antigens. Both modified live and inactivated parenteral vaccines are available. Subunit FHV-vaccines and modified intranasal vaccines have been available previously or are available outside Europe, however they are not currently available in Europe.

Both inactivated and modified live FHV-1 vaccines have relative advantages and disadvantages. There is generally little reason to prefer any specific FHV vaccine for routine vaccination, particularly since these are all based on a single serotype. Modified live vaccines retain some pathogenic potential and may rarely induce disease if administered incorrectly, i.e. accidentally aerosolised or intake of vaccine virus spilt on the skin.

The value of serological tests in predicting protection is controversial. Methodological issues can complicate comparison of titres and some suggest that titres are not good predictors of protection. In other studies, cats without any evidence of seroconversion appear to show protection (Lappin et al., 2002; Mouzin 2004). Cats that have been vaccinated usually develop an anamnaestic response following exposure.

ABCD guidelines on Feline Herpes Virus-1 10/17 2.7.1 Primary vaccination course ABCD recommends that all kittens should be vaccinated against FHV-1. Maternally derived immunity can interfere with the response to vaccination and the primary course of vaccination is usually started at around nine weeks of age, although some vaccines are licensed for use at an earlier age. Kittens should receive a second vaccination two to four weeks later, with the second given around twelve weeks of age. This protocol has been developed to ensure optimal protection. For longer intervals, no information is available and a new primary vaccination course should be considered.

In contrast to vaccines against certain other infectious agents, where single vaccination is acceptable for cats of unknown or uncertain vaccination status, in the case of FHV-1, they should also receive two vaccinations at an interval of two to four weeks, irrespective of the vaccination type.

2.7.2 Booster vaccinations Vaccination against FHV-1 prevents disease, reduces virus shedding and recrudescence.

Although the issue of recommended intervals between boosters is controversial, in view of currently available scientific evidence, ABCD recommends that boosters should be given at annual intervals to protect individual cats against FHV-1 field infections, with the exception of cats in low-risk situations (e.g. indoor-only cats without contact to other cats). In these cases, three-yearly intervals would be recommended. An informed decision should be made on the basis of a risk-benefit analysis, but annual boosters are particularly important to cats that may be exposed to high risk situations e.g. entry to boarding catteries, breeding cats.

Experimental studies and serological studies in field situations clearly indicate that immunity against FHV lasts longer than one year in most vaccinated cats (Lappin et al., 2002, Mouzin et al., 2004). However, there is a significant proportion of cats for which this is not true. Field studies have shown that almost 100% of cats either have serological titres against FCV and FPV, or show an anamnestic response following administration of a booster vaccine, but around 30% of the cat population appear to have no detectable titres against FHV and around 20% fail to show an anamnestic response following booster vaccinations (Lappin et al., 2002, Mouzin et al., 2004). Assessment of the duration of protection is complicated by failure of vaccination to provide 100% clinical protection shortly after vaccination has been administered, but in experimental vaccine efficacy studies, the efficacy of protection afforded by vaccination clearly decreases with time.

If booster vaccinations have lapsed, a single injection is considered adequate if the interval since the last vaccination is less than three years, but if it is more than three years, two vaccinations should be considered to ensure that optimal protection is provided.

Boosters using FHV vaccines produced by another manufacturer are acceptable.

Cats that have recovered from disease associated with FHV may not have lifelong protection against further episodes of disease. Furthermore, in most cases, definitive identification of the infectious agent involved in diagnostic testing will not usually have been undertaken and the cat may be susceptible to infection with other respiratory tract pathogens. Therefore, vaccination of recovered cats is generally recommended.

ABCD guidelines on Feline Herpes Virus-1 11/17

2.8 Feline herpesvirus disease control in specific situations 2.8.1 Shelters FHV-1 can represent a particular problem in cat shelters. Management to prevent and limit the potential for transfer of infection is as important as vaccination in control. In shelters where the incoming cats are mixed, very high infection rates for FHV-1 are frequently encountered. New cats should be quarantined for the first two weeks and cats should be kept individually – unless known to originate from the same household. The design of the shelter and management used should be aimed at avoiding cross infection of cats. New cats should be vaccinated as soon as possible once they have been assessed as healthy and no contraindications to vaccination have been identified. If there is a particular high risk, i.e. past or recent infection with FHV-1 in the shelter, a modified live vaccine may be preferable as it may provide earlier protection. If acute respiratory infection occurs in a shelter, definitive diagnosis of the agent involved with differentiation of FHV-1 and FCV can be useful in deciding on the appropriate preventative measures that should be adopted.

2.8.2 Breeding catteries FHV-1 can be a major problem in breeding catteries. Infection most often appears as an infection in young kittens prior to weaning. It typically occurs at around 4-8 weeks as maternally derived immunity (MDI) wanes. The source of infection is frequently the mother who is a carrier and has shown reactivation of latent infection following the stress of kittening and lactation.

Pages:     | 1 || 3 | 4 |

Similar works:

«SUMMARY OF DOCTORAL THESIS National University of Public Service Doctoral Committee EUR. ERG. DR. GYULA SZABÓ Methodology of Military Service Related Ergonomic Risk Evaluation The author’s words to PhD thesis Budapest 2012 NATIONAL UNIVERSITY OF PUBLIC SERVICE EUR. ERG. DR. GYULA SZABÓ Methodology of Military Service Related Ergonomic Risk Evaluation The author’s words to PhD thesis Academic mentor: Prof. Dr. Lajos Berek Budapest 2012 Despite continuous efforts, diseases of the...»

«1 CHAPTER 10 PROBABILITY Introduction:When a Fair coin is tossed, the face shown up is head or tail. Before tossing the coin, it is not possible to predict which face shows up. Such experiments where the outcomes cannot be predicted with certainty are called Random experiments. Random experiment and phenomena are the heart of probability theory which owes its origin to the study of games of chance or gambling. B.PASCAL(1623-1662)and PIERRE de FERMAT(1601-1665), both French mathematicians were...»

«A PUBLICATION OF DEFENSE SOAP LLC AN INTRODUCTION TO PREVENTING SKIN INFECTIONS AMONG COMBAT ATHLETES THE STEP-BY-STEP GUIDE TO SKIN DISEASES AND HOW YOU CAN PREVENT THEM. BY GUY SAKO A word about this book, The information contained in this book is for informational and educational purposes only. It is not intended to offer medical advice or to offer medical diagnoses or to suggest treatments. All of this information, the theories of skin biology, and prevention tips are derived from my own...»

«HARD RAIN a thriller by Barry Eisler Evening cherry blossoms: I slip the inkstone back into my kimono this one last time. death poem of the poet Kaisho, 1914 PART I Had I not known that I was dead already I would have mourned my loss of life. last words of Ota Dokan, scholar of military arts and poet, 1486 Chapter 1 Once you get past the overall irony of the situation, you realize that killing a guy in the middle of his own health club has a lot to recommend it. The target was a yakuza, an iron...»

«CONNECTICUT LAW REVIEW VOLUME 46 JULY 2014 NUMBER 5 Article Public Health Regulation and the Limits of Paternalism DAVID ADAM FRIEDMAN This Article explores the role of paternalism in regulatory efforts to improve public health, focusing mostly on obesity, but also accounting for recent developments in other public health arenas. First, the Article describes a spectrum of interventions that regulators can implement in the public health zone, ranging from soft paternalism to hard paternalism....»

«A Check-List for Handle Design Michael Patkin Department of Surgery The Royal Adelaide Hospital, South Australia Patkin, M. (2001). A checklist for handle design. Ergonomics Australia On-Line, 15 (supplement). (http://ergonomics.uq.edu.au/eaol/handle.pdf) This checklist was first developed and published for surgical workshops in Sydney, Australia, in 1969 and has been revised since then at conferences in Israel, Australia, and the People's Republic of China. A definitive version of this...»

«PATIENT INFORMATION LEAFLET ® Flagyl S 200mg/5ml Oral Suspension (metronidazole benzoate) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not...»

«Killing Them Softly December 2014 Killing Them Softly How Saudi Ban on Women’s Sports is Harming Their Health MS. OSSOB MOHAMUD MR. ALI AL-AHMED ‫معهد شؤون الخليج‬ Institute for Gulf Affairs 1 Killing Them Softly December 2014 Killing Them Softly? Women in Saudi Arabia are being killed softly by their government. Not by public executions or brutal rapes and beatings, but by day-to-day restrictions imposed on them by their government. Decades ago, the Salafi/Wahhabi religious...»

«Diane Randall Consults Whole Living Consultant and Workshop Presenter Media Kit Whether it is about life balance, health or self-care, my favorite wellness conversations have to do with well-being. It’s exciting to see what happens when we take the time to focus and act upon what we really want in order to realize our true goals.” -Diane Randall From health crisis to globetrotting health consultant: sharing my wellness story Included in this Media Kit About Diane Randall Recent Media...»

«Crop Profile for Mint in Wisconsin Prepared: January, 1999 General Production Information Mint has been grown commercially in Wisconsin since 1943 when peppermint was introduced to the state on a trial basis to determine whether Wisconsin soils and climate were suitable for cultivation of the crop. Wisconsin ranks 2nd in the nation for spearmint (Mentha spicata, M. cardiaca) production with 6200 acres harvested in 1995 and 5th in the production of peppermint (Mentha piperita) harvesting 7300...»

«m e n u marketing program M e n u M a r k e t i n g Guide Contents Introduction So what is SYSCO shape? What SYSCO shape is not: Section One Serving for Health Consider the facts: Section Two Understanding Food and Nutrition Average diet Eating to lose weight and prevent disease Eating for personal or environmental reasons Section Three Offering Something for Everyone Step 1: Identify existing menu items that conform to diets 10 items on your menu that are low-fat and heart healthy 4 items that...»

«PAYING FOR PERSONALIZED MEDICINE How Alternative Payment Models Could Help Or Hinder The Field EXECUTIVE SUMMARY PAYING FOR PERSONALIZED MEDICINE: HOW ALTERNATIVE PAYMENT MODELS COULD HELP OR HINDER THE FIELD EXECUTIVE SUMMARY At a time of unprecedented scientific and medical breakthroughs, personalized medicine has the capacity to more accurately diagnose human diseases, predict individual susceptibility to disease based on genetic or molecular factors, detect the onset of disease at early...»

<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.